Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04908956
Title Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO) (STEREO)
Acronym STEREO
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Thoracic Oncology Platform
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | POL | NLD | ITA | ESP | CHE


No variant requirements are available.